Health Trials

Triple Negative Breast Cancer(TNBC)

1

Review clinical trials related to Triple Negative Breast Cancer(TNBC). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC

This multicenter, randomized, double-blind study will evaluate the safety and efficacy of PM8002 in combination with Nab-Paclitaxel compared with placebo combined with Nab-Paclitaxel as first-line treatment in inoperable locally advanced/metastatic triple-negative breast cancer(TNBC)

Participants needed: 360
Trial details
Phase: Phase 3Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Biotheus Inc.Updated: Mar 12, 2025Locations: 70
Eligibility criteria

Ability to understand and willing to provide written informed consent and to com... [+6]

Previous treatment with immune checkpoint agonists (such as CD137 agonists) or i... [+8]

Read more